Lexaria Bioscience Corp (LEXX)

[damAcon1]

Wanting the ability to RS versus needing to RS to stay on a major exchange are two different things. The last RS was a necessity to uplist to Nasdaq, that was an easier pass because shareholders were under the impression that institutions would invest (some have...but is hasn't helped the stock price) and that the company had deals lined up (???). Now what is the reason? They are acting like it is to maintain the listing...but it really isn't. It is for them to maintain a stock price that they think is inticing to institutional investors. What I don't understand is why they feel the need to get an RS on the books? The last RS was a 1:2 to 1:30.. and they took the full option. This time they probably will do the same. Seems like an easy, dilute the pig and then sweep it under the rug. The company is supposed to be in their best position, have this pending IND, several other irons in the fire, etc...I mean the US govt could even reschedule cannabis! If they become out of bid compliance they can delay/extend for up a year after being out of compliance before needing to RS. Do they not have enough going on in the next year+ to, organically, lift the stock? Requesting this RS seems completely out of touch and is a giant red flag...compared to the company news that they have released. What are they hiding? What aren't they telling shareholders (besides the constant need for money to research)?